to assess the response to encainide in patients with malignant arrhythmias , we treated 22 patients with recurrent ventricular tachycardia ( vt ) or fibrillation ( vf ) refractory to an average of 5.7 drugs .
C0085251
encainide
C0003811
arrhythmias